Maryline Debette‐Gratien

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

Christophe Corpechot, Olivier Chazouillères, Alexandra Rousseau et al. · New England Journal of Medicine · 2018 · 611 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma

Jean–Louis Jouve, Thierry Lecomte, Olivier Bouché et al. · Journal of Hepatology · 2019 · 114 citations

Medicine, Oncology, Pharmacology +13

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence – The ANRS CUPILT study

Audrey Coilly, Claire Fougerou‐Leurent, Victor de Lédinghen et al. · Journal of Hepatology · 2016 · 83 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients

Olivier Serée, Mario Altieri, Élodie Guillaume et al. · Liver Transplantation · 2018 · 68 citations

Medicine, Oncology, Surgery +17

A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

Christophe Corpechot, Olivier Chazouillères, Antoine Rousseau et al. · Journal of Hepatology · 2017 · 46 citations

Medicine, Internal Medicine, Pharmacotherapy +12